Cite
MLA Citation
Mario Campone et al.. “A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial).” European journal of cancer, vol. 158, 2021, pp. 169–180. http://access.bl.uk/ark:/81055/vdc_100145647470.0x00002c